InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,620.85
(
0.42%
)
US TECH 100
19,300.00
(
0.00%
)
Dow Jones
40,890.49
(
0.14%
)
Brent Oil
75.50
(
-0.25%
)
Bitcoin
60,828.42
(
3.09%
)
Post# of 252939
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 837
Posts 120317
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: quantumdot post# 72854

Friday, 02/06/2009 11:52:32 AM

Friday, February 06, 2009 11:52:32 AM

Post# of 252939
IDIX – In #msg-34894217 I was clearly referring to the gross up-front cash, not the portion of it excluding equity:

$25M would make the arithmetic in #msg-34813718 work—barely. Hence, I think it’s reasonable to consider $25M a lower bound for the up-front amount.

At $6.87/sh, the $17M of new equity from the GSK deal translates into 2.47M new shares, which is roughly a 4% expansion in the shares outstanding. I’m OK with that.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up